XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Stock award plan - (Tables)
3 Months Ended
Mar. 31, 2025
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2024

 

8,482,489

$

42.29

 

  

 

  

Granted

 

802,745

$

46.74

 

  

 

  

Exercised

 

(431,089)

$

36.98

 

  

 

  

Forfeited/Cancelled

 

(320,327)

$

50.32

 

  

 

  

Outstanding at March 31, 2025

 

8,533,818

$

42.68

 

5.93

years

$

91,932

Expected to vest at March 31, 2025

 

1,802,150

$

38.47

 

8.81

years

$

22,683

Exercisable at March 31, 2025

 

6,512,960

$

43.96

 

5.02

years

$

66,629

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Three months ended

    

    

March 31, 2025

    

Risk-free interest rate

 

4.12% - 4.44%

 

Expected volatility

 

55%

 

Expected term

 

5.5 years

 

Summary of information on the Company's restricted stock

Restricted Stock Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2024

3,527,575

$

33.39

Granted

 

1,537,675

46.76

Vested

 

(1,089,999)

36.71

Forfeited

 

(102,270)

33.26

Unvested at March 31, 2025

 

3,872,981

$

37.77

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended March 31, 

    

2025

    

2024

    

Research and development

$

8,663

$

8,967

Selling, general and administrative

 

9,397

 

9,411

Total

$

18,060

$

18,378